Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

StarVR Unveils Advanced Virtual Reality Headset with Integrated Tobii Eye Tracking

STOCKHOLM, Aug. 14, 2018 /PRNewswire/ -- Today, at the annual Siggraph Conference, StarVR unveiled its upcoming StarVR® One virtual reality headset, featuring advanced optics, integrated eye tracking, industry-leading field of view, and sophisticated rendering technology.

"Over the last few years, Tobii has shown that integrated eye tracking is a foundational technology for next generation VR devices," said Henrik Eskilsson, CEO of Tobii. "The StarVR One headset represents an important proof point for the many ways that eye tracking fundamentally leads to enhanced experiences."

In September of 2015, Tobii and Starbreeze announced a VR development collaboration. Due to that successful collaboration, the StarVR One headset will include seamless and industry-leading eye-tracking technology, enhancing the device with capabilities to support dynamic foveated rendering, and automatic interpupillary distance (IPD) measurement.

In addition to enhancing the device, eye tracking will create better user experiences by enabling interactions in virtual reality that streamline the user interface, emulate true hand-eye coordination, and allow expressive eye contact. For more information on how eye tracking creates better devices and better experiences, visit the Tobii website.

Tobii's scope of delivery for the StarVR One headset includes the Tobii EyeChip and licenses for Tobii's system design, IP and software. Information about product availability, pricing, and order volume commitment is not yet available.

Additional information and specifications for the new StarVR One headset can be found on the company's web page www.starvr.com.

This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on August 14, 2018, at 8:45 p.m. CET


Sara Hyléen, Director of Communications and Investor Relations, Tobii AB, phone: +46 709 16 16 41, email: sara.hyleen@tobii.com

Ben Conrad, Vice President of Media and Influencers, Tobii Tech, phone: +1 (650) 224-6261, email: ben.conrad@tobii.com

This information was brought to you by Cision http://news.cision.com


The following files are available for download:


StarVR Unveils VR Headset with Tobii Eye Tracking - press release - 14Aug2018


StarVR One 02 white background


StarVR One 03 white background


These press releases may also interest you

at 05:00
TestCard, the UK-based health tech company, announced today it has completed a seed round of financing led by Neo Ventures (www.neoventures.net). In 2018 TestCard will launch its at-home urine test solution, providing consumers and patients with...

at 05:00
NEWARK, N.J., Sept. 25, 2018 /PRNewswire-PRWeb/ -- Newark Venture Partners (NVP), a leading East Coast early-stage venture fund, today announced the start of its Fall 2018 NVP Labs program. The newest cohort of 8 startups is made up of companies...

at 05:00
VANCOUVER, BC, September 25, 2018  /PRNewswire-PRWeb/ -- Canada Drug Rehab (CDR), a top resource of Canadian drug rehab and alcohol treatment programs, is proud to announce a new post on so-called "Sober Living" strategies. Sober living throughout...

at 05:00
The Arbor Company, a premier operator of outstanding senior living communities, today announced it is publishing a comprehensive resource to assist families in considering, researching, choosing, and helping their loved ones move into a senior living...

at 05:00
BOSTON, Sept. 25, 2018 /PRNewswire-PRWeb/ -- Springfield, Mo.-based pressure vessel fabrication company HOLLOWAY AMERICA recently announced it will attend and exhibit at the ISPE Boston Area Chapter Product Show at the Gillette Stadium in Foxboro,...

at 04:20
The global biosimilars market size is expected to reach a value of USD 61.47 billion by 2025, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 34.2% over the forecast period. Major biological drugs are...

News published on 14 august 2018 at 15:14 and distributed by: